
Century Therapeutics Inc
IPSCNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$2.39
Day High
$2.45
Day Low
$2.32
Prev. Close
$2.39
VolumeShares traded today.
1.19M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$441.87M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-2.21
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$3.04
52W LowLowest price over the past 52 weeks.
$0.4400
50D MAAverage closing price over the last 50 trading days.
$2.28
200D MAAverage closing price over the last 200 trading days.
$1.39
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+7.9%1M
+11.4%6M
+360.5%YTD
+146.3%1Y
+361.9%About
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.
www.centurytx.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade IPSC
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.